Glycated Albumin for Glycemic Control in T2DM Population: A Multi-Dimensional Evaluation.
Lucrezia FerrarioFabrizio SchettiniAngelo AvogaroChiara BelliaFederico BertuzziGraziella BonettiAntonio CerielloMarcello CiaccioMassimiliano Corsi RomanelliElena DozioLuca FalquiAngela GirelliAntonio NicolucciGianluca PerseghinMaria Rosaria CapobianchiUmberto ValentiniMartina ZaninottoSilvana CastaldiEmanuela FogliaPublished in: ClinicoEconomics and outcomes research : CEOR (2021)
Adding GA to traditional glycaemic control instruments could improve the clinical pathway of individuals with T2DM, leading to economic and organisational advantages for both hospitals and National Healthcare Systems.